Andrew Muir, MD, MHS, Clinical Director Hepatology

Department:
Medicine

Division:
Gastroenterology

Physical Address:
DUMC 3913, Durham, NC 27710

Appointment Telephone:
(919) 684-2052

Fax Telephone:
(919) 684-8264

Training:
M.D., Duke University School of Medicine, North Carolina, 1993
Internal Medicine, Duke University Medical Center, North Carolina, 1993-96
Gastroenterology, Duke University Medical Center, North Carolina, 1996-97, 1998-2000

Clinical Interests:
General and transplant hepatology

Publications:
2008 -- Pubmed # 18236402 -- Brady CW, Smith AD, Stechuchak KM, Coffman CJ, Tuttle-Newhall JE, Provenzale D, Muir AJ. Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era. Liver Transpl. 2008 Feb;14(2):228-34.

2008 -- Pubmed # 18519925 -- Jou JH, Muir AJ. In the clinic. Hepatitis C. Ann Intern Med. 2008 Jun 3;148(11):ITC6-1-ITC6-16.

2008 -- Pubmed # 18486984 -- Lawitz E, Rodriguez-Torres M, Muir AJ, Kieffer TL, McNair L, Khunvichai A, McHutchison JG. Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients. J Hepatol. 2008 Aug;49(2):163-9.

2006 -- Pubmed # 16644828 -- Patel K, Muir AJ, McHutchison JG. Diagnosis and treatment of chronic hepatitis C infection. BMJ. 2006 Apr 29;332(7548):1013-7.

2006 -- Pubmed # 17164121 -- Ramamurthy M, Muir AJ. Treatment of hepatitis C in special populations. Clin Liver Dis. 2006 Nov;10(4):851-65.

2005 -- Pubmed # 16003247 -- Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation. 2005 Jul 15;80(1):145-8.

2004 -- Pubmed # 15163776 -- Muir AJ, Bornstein JD, Killenberg PG, . Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med. 2004 May 27;350(22):2265-71.